← Open Payments lookup

YEISELL DUCONGE MUNARRIZ: Open Payments

NPI 1346744166 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$785 in 33 payments from 10 companies in 2025. Trend: 2023 $889 · 2024 $833 · 2025 $785

Food & beverage: $785
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$205
Lundbeck LLC6$142
Janssen Pharmaceuticals, Inc5$121
Axsome Therapeutics, Inc.4$85
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$75
Vanda Pharmaceuticals Inc.2$60
Teva Pharmaceuticals USA, Inc.2$42
E.R. Squibb & Sons, L.L.C.1$27
Neos Therapeutics, LP1$15
Alkermes, Inc.1$14

Products named: REXULTI, INVEGA SUSTENNA, Auvelity, CAPLYTA, FANAPT, AUSTEDO XR, COBENFY, Adzenys XR-ODT.

Industry payments across FL — which companies pay providers there.